Hangzhou Biotest BiotechLtd Balance Sheet Health
Financial Health criteria checks 6/6
Hangzhou Biotest BiotechLtd has a total shareholder equity of CN¥2.4B and total debt of CN¥347.6K, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are CN¥2.6B and CN¥153.2M respectively. Hangzhou Biotest BiotechLtd's EBIT is CN¥14.4M making its interest coverage ratio -0.1. It has cash and short-term investments of CN¥1.8B.
Key information
0.01%
Debt to equity ratio
CN¥347.56k
Debt
Interest coverage ratio | -0.1x |
Cash | CN¥1.77b |
Equity | CN¥2.42b |
Total liabilities | CN¥153.17m |
Total assets | CN¥2.57b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688767's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥141.1M).
Long Term Liabilities: 688767's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥12.0M).
Debt to Equity History and Analysis
Debt Level: 688767 has more cash than its total debt.
Reducing Debt: 688767's debt to equity ratio has reduced from 22% to 0.01% over the past 5 years.
Debt Coverage: 688767's debt is well covered by operating cash flow (59837%).
Interest Coverage: 688767 earns more interest than it pays, so coverage of interest payments is not a concern.